PD-Rx Net Complies With Reporting Requirements of Controlled Substances in 9 States OKLAHOMA CITY, March 10 /PRNewswire-FirstCall/ -- PD-Rx Pharmaceuticals, Inc. (OTC Pink Sheets: PDRX), a publicly held corporation, today announced that it has completed the software development necessary to comply with nine separate states' reporting requirements on controlled prescription medications. A proprietary software program called "PD-Rx Net", will be able to transmit the transaction history file of all prescribed medications electronically to each state and their respective law enforcement agency to review for the prescription drug abuse. Shawn Stephens, the MIS Director with PD-Rx Pharmaceuticals states, "The new programming changes to 'PD-Rx Net' will allow each state to monitor drug trends and patterns of prescription drug abuse. The information collected with the use of the 'PD-Rx Net System' will be essential in controlling the abuse and diversion of controlled substances." When asked about the multi-dimensional state requirements of Pedigrees documentation, Mr. Stephens stated: "We've actually expanded our staff in order to quickly innovate, deploy, and meet the emerging requirement of each state to track the movement of pharmaceutical products throughout the United States." With the development and use of computer programs like "PD-Rx Net" and the automation of data collection, each state and its law enforcement agencies will have the opportunity to monitor drug diversion and crack down on criminals and other abused substances in the pharmaceutical market. ABOUT THE COMPANY PD-Rx offers pharmaceutical and management strategies to the healthcare industry. Our management strategies focus on new products, solid business partners, and the specialized segment of the pharmaceutical industry. As a licensed FDA manufacturer and repackager, PD-Rx offers a full spectrum of medications and specialized services. Our goal is to develop a matrix of cost containment tools and products that we can merge into any healthcare network to enhance patient care and improve managed care organizations bottom line. We provide proprietary products and prepackaged medications that are viewed by patient, insurance payers, and healthcare providers as a progressive and responsive practice. This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks and uncertainties or other factors, which may cause actual results, performance or achievements expressed or implied by such forward-looking statements to vary from those forecast or implied in this release. Factors that might cause such a difference include, without limitation, decline in demand for the company's products or services, and the effect of general economic conditions and factors affecting the industry. DATASOURCE: PD-Rx Pharmaceuticals, Inc. CONTACT: Jack L. McCall, EVP & COO of PD-Rx Pharmaceuticals, Inc., +1-405-942-3040

Copyright